Finding Balance: Hanbang, Mindfulness, and Mental Well-being in Modern Korea — Epoche C1
The problem the two practices are being offered against South Korea has recorded the highest suicide rate among OECD member countries for most of the past two decades, at roughly twenty-five deaths per hundred thousand people a year against an OECD average near eleven, a position it still held in the organisation's Health at a Glance 2023 . That is the concrete problem behind the general talk of pressure and burnout, and it sets the standard against which any proposed remedy has to be judged. This essay takes the compressed version's two candidates — hanbang (한방), the Korean medical tradition, and secular mindfulness meditation — and asks of each what it consists of, what has been measured about it, how large the measured effect is when converted into a quantity a reader can interpret, and what harms have been looked for. It then asks what the proposed synthesis of the two would have to establish to be more than a hope. The conclusion, stated at the outset so that the reasoning can be followed rather than awaited: both practices have real but small measured effects on mood and anxiety, neither has been shown superior to an active alternative, the compressed version overstated the accessibility of one and the antiquity of the other, and the integration it proposes has a specific pharmacological hazard that nothing in the original acknowledged. What hanbang is, and how old it actually is Hanbang is not simply the Korean branch of a single East Asian medicine, and its documented history is shorter and more specific than "millennia" suggests. The systematised Korean tradition is conventionally dated from the Donguibogam (동의보감, "Precious Mirror of Eastern Medicine"), compiled under royal commission by the court physician Heo Jun and completed in 1610, published in 1613 — a twenty-five-volume synthesis of Chinese and Korean medical writing organised, unusually, by the body's internal states rather than by disease name. UNESCO added it to the Memory of the World Register in 2009, which is a recognition of documentary heritage and says nothing about clinical efficacy; the two are routinely conflated in promotional writing and should not be. The doctrine the compressed version invoked under the word chejil (체질, constitution) is more recent still and is the genuinely Korean contribution. It comes from the Donguisusebowon (동의수세보원) of Lee Je-ma, published in 1894, which founded Sasang (사상) constitutional medicine. Lee's system sorts people into four constitutional types — Taeyang , Taeeum , Soyang and Soeum — held to differ in the relative development of the internal organs, in temperament, and therefore in which herbs will help and which will harm. The practical consequence, and the reason this matters for evidence rather than for ethnography, is that a Sasang prescription is type-specific by construction: the same complaint in two patients of different types calls for different formulae. That is what practitioners mean by a personalised approach, and it is also why conventional trial designs sit awkwardly on the tradition, since randomising patients to a single standardised formula tests something the doctrine does not claim. Institutionally, Korea is unusual in a way that shapes everything downstream. Under the Medical Service Act, doctors of Korean medicine (한의사) hold a separate national licence from doctors of conventional medicine, train in their own six-year colleges, run their own clinics and hospitals, and are reimbursed by National Health Insurance for a defined range of treatments. This is a parallel profession with statutory standing, not a fringe. It also means that a patient may hold two prescriptions from two licensed prescribers who have no shared record, a fact that becomes important later in this essay. Reading the evidence: what an effect size is worth The compressed version wrote that hanbang's efficacy for clinical depression "can be limited". The evidence supports a firmer statement, and following it requires one piece of technical vocabulary and one short derivation. Trials of psychological and psychiatric treatments usually report a standardised mean difference : the gap between the treated and control group means, divided by the pooled standard deviation of the outcome measure, so that results from different depression scales can be combined. Call it $d$. The convention is that $0.2$ is small, $0.5$ moderate and $0.8$ large, but the convention conveys little, so it is worth converting $d$ into something with an interpretation. Suppose outcomes in the treated and control groups are normally distributed with a common variance $\sigma^2$ and means $\mu_1$ and $\mu_2$, and take one person at random from each. The difference $X - Y$ of two independent normal variables is normal with mean $\mu_1 - \mu_2$ and variance $2\sigma^2$, so the probability that the treated person does better is $$P(X \gt Y) \;=\; \Phi\Big(\frac{\mu_1-\mu_2}{\sigma\sqrt{2}}\Big) \;=\; \Phi(d/\sqrt{2}),$$ with $\Phi$ the standard normal distribution function. For $d = 0.3$ this gives $\Phi(0.21) \approx 0.58$. In other words, a treatment with a standardised effect of $0.3$ is one where, picking a treated and an untreated person at random, the treated one does better about fifty-eight times in a hundred rather than fifty. That is a real effect. It is not a transformation, and it is the magnitude that most of what follows turns out to be. With that in hand: the Cochrane systematic review of acupuncture for depression (Smith, Armour, Lee, Wang and Hay, 2018), which pooled sixty-four trials, reported a moderate reduction in depression severity when acupuncture was compared with no treatment or with usual care, but graded the certainty of that evidence as low — meaning that further research is likely to change the estimate — on account of small samples, unclear randomisation and unblinded assessment. Against sham acupuncture the difference was small and of very low certainty. There is a further and more uncomfor